Stable immunogenic product comprising antigenic heterocomplexes

Details Stable immunogenic product comprising antigenic heterocomplexes Stable immunogenic product comprising antigenic heterocomplexes

2011-07-05

2011-07-05

Woodward, Cherie M (Department: 1647)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S188100, C530S350000

Reexamination Certificate

active

07972603

ABSTRACT:
The invention relates to a stable immunogenic product for the induction of antibodies against one or more antigenic proteins in a subject. The invention is characterised in that it comprises proteinaceous immunogenic heterocomplexes which are formed by associations between (i) antigenic protein molecules and (ii) proteinaceous carrier molecules and in that less than 40% of the antigenic proteins (i) are linked to the proteinaceous carrier molecules (ii) by a covalent bond.

REFERENCES:
patent: 5008116 (1991-04-01), Cahn
patent: 6093405 (2000-07-01), Zagury et al.
patent: 6340461 (2002-01-01), Terman
patent: 6455045 (2002-09-01), Zagury et al.
patent: 6878370 (2005-04-01), Zagury et al.
patent: 7022482 (2006-04-01), Zagury et al.
patent: 2002/0098203 (2002-07-01), Gustavsson et al.
patent: 2004/0028647 (2004-02-01), Zagury et al.
patent: WO 9101146 (1991-02-01), None
patent: WO 9846642 (1998-10-01), None
patent: WO 9957981 (1999-11-01), None
patent: WO 0211759 (2002-02-01), None
patent: WO 0222164 (2002-03-01), None
Tam, J Immunol Methods Sep. 13, 1996;196(1):17-32.
Wedlock et al., Immunol and Cell Biology. 1999; 77:28-33.
Antigen Design and Sera Purification, Sigma Genosys, 2006.
Musselli et al., J Cancer Res Clin Oncol. Oct 2001: 127(Suppl 2):R20-R26).
Shirakawa et al, “VEGF121-specific monoclonal antibodies, hybridomas producing them, and determination of VEGF using the antibodies,” Chemical Abstracts Service, 1999, XP00224246.
Kim et al., “Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUCI-KLH and GD3-KLH conjugate cancer vaccines,” Vaccine 18, (2000), pp. 597-603, XP002242468.

Affiliated with

Also associated with

Rating

Stable immunogenic product comprising antigenic heterocomplexes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stable immunogenic product comprising antigenic heterocomplexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable immunogenic product comprising antigenic heterocomplexes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2727655